Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.
2.

Portable home phototherapy for vitiligo.

Eleftheriadou V, Ezzedine K.

Clin Dermatol. 2016 Sep-Oct;34(5):603-6. doi: 10.1016/j.clindermatol.2016.05.010. Epub 2016 May 20.

PMID:
27638439
3.

Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.

Asawanonda P, Kijluakiat J, Korkij W, Sindhupak W.

Acta Derm Venereol. 2008;88(4):376-81. doi: 10.2340/00015555-0469.

4.

Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.

Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W.

J Eur Acad Dermatol Venereol. 2007 Aug;21(7):942-50.

PMID:
17659004
5.

Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.

Dell'Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, Leone G, Calzavara PG, Westerhof W, Picardo M.

Clin Exp Dermatol. 2007 Nov;32(6):631-6.

PMID:
17953631
6.

Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.

Verhaeghe E, Lodewick E, van Geel N, Lambert J.

Dermatology. 2011;223(4):343-8. doi: 10.1159/000335272. Epub 2012 Jan 24.

PMID:
22269666
7.

Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.

Li R, Qiao M, Wang X, Zhao X, Sun Q.

Photodermatol Photoimmunol Photomed. 2017 Jan;33(1):22-31. doi: 10.1111/phpp.12277. Epub 2016 Nov 23. Review.

PMID:
27696531
8.

Interventions for vitiligo.

Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K.

Cochrane Database Syst Rev. 2015 Feb 24;(2):CD003263. doi: 10.1002/14651858.CD003263.pub5. Review.

PMID:
25710794
9.

Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.

Stanimirovic A, Kovacevic M, Korobko I, Šitum M, Lotti T.

Dermatol Ther. 2016 Sep;29(5):312-316. doi: 10.1111/dth.12363. Epub 2016 Jun 30.

PMID:
27356486
10.

Simultaneous improvement and worsening of vitiligo lesions during the course of NB-UVB phototherapy; vitiligo may not act as one unit.

Anbar T, Abdel-Rahman A, Hegazy R, El-Khayyat M, Ragaie M.

Dermatol Ther. 2017 Jan;30(1). doi: 10.1111/dth.12420. Epub 2016 Sep 9.

PMID:
27611118
11.

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease.

Thomas KS, Batchelor JM, Bath-Hextall F, Chalmers JR, Clarke T, Crowe S, Delamere FM, Eleftheriadou V, Evans N, Firkins L, Greenlaw N, Lansbury L, Lawton S, Layfield C, Leonardi-Bee J, Mason J, Mitchell E, Nankervis H, Norrie J, Nunn A, Ormerod AD, Patel R, Perkins W, Ravenscroft JC, Schmitt J, Simpson E, Whitton ME, Williams HC.

Southampton (UK): NIHR Journals Library; 2016 Dec.

12.

Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.

Asawanonda P, Klahan SO.

Photomed Laser Surg. 2010 Oct;28(5):679-84. doi: 10.1089/pho.2009.2637.

PMID:
20961233
13.

The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.

Ibrahim ZA, El-Ashmawy AA, El-Tatawy RA, Sallam FA.

J Cosmet Dermatol. 2016 Jun;15(2):108-16. doi: 10.1111/jocd.12194. Epub 2015 Dec 23.

PMID:
26695436
14.

Vitiligo, NB-UVB and tacrolimus: our experience in Naples.

Baldo A, Lodi G, Di Caterino P, Monfrecola G.

G Ital Dermatol Venereol. 2014 Feb;149(1):123-30.

PMID:
24566573
15.

Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.

Yones SS, Palmer RA, Garibaldinos TM, Hawk JL.

Arch Dermatol. 2007 May;143(5):578-84. Erratum in: Arch Dermatol. 2007 Jul;143(7):906.

PMID:
17519217
16.

The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.

Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S.

J Dermatolog Treat. 2009;20(1):14-8. doi: 10.1080/09546630802155057.

PMID:
18608735
17.

Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.

Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G.

J Eur Acad Dermatol Venereol. 2007 Aug;21(7):956-63.

PMID:
17659006
18.

Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis.

Lopes C, Trevisani VF, Melnik T.

Am J Clin Dermatol. 2016 Feb;17(1):23-32. doi: 10.1007/s40257-015-0164-2. Review.

PMID:
26520641
19.

A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.

Bakis-Petsoglou S, Le Guay JL, Wittal R.

Br J Dermatol. 2009 Oct;161(4):910-7. doi: 10.1111/j.1365-2133.2009.09252.x. Epub 2009 Jun 11.

PMID:
19523170
20.

Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.

Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G.

J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1369-74.

PMID:
17958843

Supplemental Content

Support Center